Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Clinical and experimental pharmacology & physiology
Patients considering GLP-1 discontinuation should work closely with their healthcare team to develop individualized maintenance plans, establish realistic expectations about weight trajectory, and implement close monitoring for weight regain
The same principles apply to tirzepatide and retatrutide, though specific guidelines for retatrutide will not exist until it reaches the market
A recent study showed that people taking semaglutide experienced a reduction of about 40% of abdominal visceral fat, which is the most dangerous type of belly fat, in a little over a year
If youd like to discuss GLP-1 therapies or have questions about your current treatment, give us a call
Given my history of [specific condition] and the difficulty I have had achieving sustained weight loss through lifestyle modification alone, this seems like an evidence-based treatment that could address the underlying biology." Notice the language
